Blirt SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
16 Pages - GLDATA62719
$250.00

Summary

Blirt SA (Blirt) is a biotechnology company that provides contract research services, and drug research and development services in the areas of oncology and antifungal. The company’s research and development product portfolio includes antifungal and cytostatic pharmaceuticals and transplant fluid. Blirt offers products such as recombinant protein and molecular biology products. Its services include protein, molecular biology and GLP analytical services, bio-analytical, DMPK and ADME, toxicology, biologics manufacturing, antibody, genomic, process research and biological research reagent manufacturing. The company caters to pharmaceutical and biotech companies. Blirt is headquartered in Gdansk, Poland.

Blirt SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Blirt SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Blirt SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Blirt SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Blirt Enters into Agreement with Rhein Biotech for Cancer Vaccine 10
Licensing Agreements 10
Blirt Plans To Out-License Antifungal Assets 10
Equity Offering 11
Blirt to Raise USD0.8 Million in Private Placement of Series L Shares 11
Blirt to Raise Funds through Private Placement of Series A Warrants 11
Blirt SA - Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Blirt SA, Pharmaceuticals & Healthcare, Key Facts 1
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Blirt SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Blirt SA, Deals By Therapy Area, 2011 to YTD 2017 8
Blirt SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Blirt Enters into Agreement with Rhein Biotech for Cancer Vaccine 10
Blirt Plans To Out-License Antifungal Assets 10
Blirt to Raise USD0.8 Million in Private Placement of Series L Shares 11
Blirt to Raise Funds through Private Placement of Series A Warrants 11
Blirt SA, Key Competitors 13
Blirt SA, Key Employees 14
Blirt SA, Other Locations 15
Blirt SA, Subsidiaries 15

List of Figures
Blirt SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Blirt SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Blirt SA, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Blirt SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Blirt SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838